Henry Prince

T-NHL subtypes and clinical perspective

H Miles Prince

Journal article  |  2021  |  Pathology

SUBTYPES OF MATURE T AND NK CELL LYMPHOMAS ACCORDING TO 2016 WHO CLASSIFICATION. PRELIMINARY REPORT OF THE INTERNATIONAL PROSPECTIVE T‐CELL PROJECT 2.0

M Federico, CS Chiattone, HM Prince, A Pavlovsky, M Manni, M Civallero, T Skrypets, CA De Souza, EA Hawkes, L Fiad, A Lymboussakis, C Tomuleasa, R Nair, J Pereira, P Pereyra, C Minoia, I Kryachok, NS de Castro, RH Advani, S Luminari

Journal article  |  2021  |  Hematological Oncology

Targeted Approaches to T-Cell Lymphoma

Sean Harrop, Chathuri Abeyakoon, Carrie Van der Weyden, H Miles Prince

Journal article  |  2021  |  JOURNAL OF PERSONALIZED MEDICINE

The T-cell lymphomas are a rare group of Non-Hodgkin's lymphomas derived from mature T-lymphocytes. They are divided broadly into ..

Advances in Frontline Management of Peripheral T-cell Lymphoma

Chathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, Amit Khot, Michael Dickinson, Costas K Yannakou, H Miles Prince

Journal article  |  2021  |  CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphomas that are frequently associated with a poor prognosis. F..

Updates from ICARIA-MM, a phase 3 study of isatuximab (Isa) plus pomalidomide and low-dose dexamethasone (Pd) versus Pd in relapsed and refractory multiple myeloma (RRMM).

Paul G Richardson, Aurore Perrot, Jesús F. San-Miguel, Meral Beksac, Ivan Spicka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A Dimopoulos, Jeffrey SY Huang, Jiri Minarik, Michele Cavo, H Miles Prince, Cheng Zheng, Franck Dubin, Helgi Van De Velde, Kenneth Carl Anderson

Journal article  |  2021  |  Journal of Clinical Oncology

8017 Background: Isa is an approved monoclonal antibody that binds to a specific epitope on the CD38 receptor. The Phase 3 ICARIA..

First-in-human study of lisaftoclax (APG-2575), a novel BCL-2 inhibitor (BCL-2i), in patients (pts) with relapsed/refractory (R/R) CLL and other hematologic malignancies (HMs).

Sikander Ailawadhi, Asher Alban Akmal Chanan-Khan, Zi Chen, Bo Huang, Marina Konopleva, Danielle M Brander, David Rizzieri, Masa Lasica, Constantine Si Lun Tam, Costas K Yannakou, H Miles Prince, Matthew Steven Davids, Zhicong He, Ming Lu, Mohammad Ahmad, Mingyu Li, Zhiyan Liang, Boyd Mudenda, Dajun Yang, Yifan Zhai

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

7502 Background: The BCL-2i venetoclax is active in certain HMs but can increase the risk of tumor lysis syndrome (TLS), requirin..

Myeloma NK cells are exhausted and have impaired regulation of activation.

Criselle D'Souza, Simon P Keam, Han Xian Aw Yeang, Michael Neeson, Kelden Richardson, Andy K Hsu, Rachael Canfield, Natalie Bezman, Michael Robbins, Hang Quach, David S Ritchie, Simon J Harrison, Joseph A Trapani, H Miles Prince, Paul A Beavis, Phillip K Darcy, Paul J Neeson

Journal article  |  2021  |  Haematologica

Not available.

An evaluation of isatuximab, pomalidomide and dexamethasone for adult patients with relapsed and refractory multiple myeloma

Anna Piggin, H Miles Prince

Journal article  |  2021  |  EXPERT REVIEW OF HEMATOLOGY

INTRODUCTION: Despite therapeutic advances, myeloma remains an essentially incurable disease, with a median survival of approximat..

Management of hydroxyurea resistant or intolerant polycythemia vera

Indu Raman, Sant-Rayn Pasricha, H Miles Prince, Costas Yannakou

Journal article  |  2021  |  LEUKEMIA & LYMPHOMA

Polycythemia vera is a Philadelphia negative myeloproliferative neoplasm characterized by erythrocytosis in which the major cause ..

COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement

Georgia McCaughan, Pietro Di Ciaccio, Michelle Ananda-Rajah, Nicole Gilroy, Raina MacIntyre, Benjamin Teh, Robert Weinkove, Jennifer Curnow, Jeff Szer, Anoop K Enjeti, David M Ross, Stephen Mulligan, Judith Trotman, Michael Dickinson, Hang Quach, Phillip Choi, Mark N Polizzotto, Constantine S Tam, P Joy Ho, Matthew Ku, et al.

Journal article  |  2021  |  INTERNAL MEDICINE JOURNAL

Australia and New Zealand have achieved excellent community control of COVID-19 infection. In light of the imminent COVID-19 vacci..